Two Pennies and a Shake

[shaolin]

ZKEM news( Thanks to Arch )............................


Xechem, Inc., a Subsidiary of Xechem International, Inc. Announces That It has Obtained Regulatory Approval to Sell Paclitaxel in India


NEW BRUNSWICK, N.J., Jul 27, 2001 (BUSINESS WIRE) -- Xechem Inc. a subsidiary
of Xechem International, Inc. (OTC BB: ZKEM) today announced that it has obtained
notice of regulatory approval to import and sell generic Chinese paclitaxel in
India.

Xechem received its notice and authorization from the Indian Government on
Friday, July 20, 2001. In addition to obtaining approval in India, Xechem is
aggressively seeking approval to import and/or sell generic paclitaxel in other
countries, including Indonesia and other Pacific Rim Countries, Africa, Europe,
South America Countries and the United States.

According to Xechem's President and CEO, Dr. Ramesh C. Pandey, "Xechem is very
excited about receiving its first regulatory approval to sell generic paclitaxel
in a major market and all of Xechem's efforts in this arena are at last coming
to fruition. Xechem will adhere to its aggressive plans to sell generic
paclitaxel and its new paclitaxel formulation (and other new generation
paclitaxel analogs) in as many geographic jurisdictions throughout the world as
possible including the United States."

Xechem International, Inc., (www.xechem.com) headquartered in New Brunswick, NJ,
with subsidiary companies in USA, India and joint venture partners in both Hong
Kong and Peoples Republic of China, is a biopharmaceutical company of which
Xechem, Inc. (a US subsidiary) is engaged in the research, development and
production of generic and proprietary drugs from natural sources, specializing
in the development of niche-generic, difficult to replicate anticancer,
antiviral (including Human Immuno-deficiency Virus, HIV), antifungal and
anti-infective compounds and screens extracts and pure compounds from various
parts of the world for their therapeutic use. XetaPharm, Inc., a subsidiary of
Xechem, develops quality controlled nutritional products such as GinkgoOnce(R),
GinsengOnce(R), GarlicOnce(R), Gugulon(TM), Co-Enzyme Q-10 and VIDA PRAS(TM) as
well as numerous other products under development. All XetaPharm products can be
seen and ordered from our website at www.xetapharm.com, at our toll-free number
(1-800-858-5854) or through a growing number of pharmacies, health food and
nutritional stores.

For further information, contact John P. Luther, Vice President and General
Counsel at (732) 247 - 3300.

This news release contains certain forward-looking statements within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, which are intended to be covered by
safe harbors created hereby. Such forward-looking statements involve known and
unknown risks, uncertainties, including the ability of the Companies to
successfully develop and commercialize their technologies, and other factors
that may cause the actual results, performance or achievements of the Companies
to be materially different from any future results, performance or achievements
of the Companies expressed or implied by such forward-looking statements.


CONTACT: Xechem International, Inc., New Brunswick
 John P. Luther, 732/247-3300

URL: http://www.businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.